Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 330.80
+1.40 (0.43%)
Oct 1, 2026, 2:24 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 20.06 million as of October 2, 2026. Its market cap has decreased by -60.84% in one year.
Market Cap
20.06M
Enterprise Value
-779.12K
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
330.80
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 20.06M, a decrease of -71.15%. That is a compound annual growth rate of -6.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 20.06M | -74.47% |
| Dec 31, 2025 | 78.55M | 38.59% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 212.60M |
| Matricelf | 78.15M |
| Clal Biotechnology Industries | 37.17M |
| BioLineRx | 36.69M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 26.91M |
| XTL Biopharmaceuticals | 23.84M |
| Evogene | 20.24M |